Journal•ISSN: 2213-2600
The Lancet Respiratory Medicine
Elsevier BV
About: The Lancet Respiratory Medicine is an academic journal published by Elsevier BV. The journal publishes majorly in the area(s): Medicine & Internal medicine. It has an ISSN identifier of 2213-2600. Over the lifetime, 2660 publications have been published receiving 148887 citations.
Topics: Medicine, Internal medicine, Population, MEDLINE, COPD
Papers
More filters
••
TL;DR: The clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) of Wuhan Jin Yin-tan hospital between late December, 2019 and Jan 26, 2020 are described.
7,787 citations
••
TL;DR: O surto do novo coronavÃrus (COVID-19) em Wuhan, China, iniciado em dezembro de 2019, evoluiu para se tornar uma pandemia global A.
6,850 citations
••
TL;DR: It is suggested that patients with cardiac diseases, hypertension, or diabetes, who are treated with ACE2increasing drugs, are at higher risk for severe COVID-19 infection and, therefore, should be monitored for ACE2-modulating medications, such as ACE inhibitors or ARBs.
2,332 citations
••
Spanish National Research Council1, Autonomous University of Madrid2, University of Queensland3, Jimma University4, United Arab Emirates University5, University of Cartagena6, University of Qom7, Mekelle University8, University of Belgrade9, Stanford University10, University of São Paulo11, Debre Berhan University12, Bahir Dar University13, Haramaya University14, Debre markos University15, University System of Georgia16, State University of New York System17, Christian Medical College & Hospital18, University of Peradeniya19, Bielefeld University20, University of Newcastle21, Newcastle University22, Howard University23, University of Delhi24, University of Mazandaran25, Juntendo University26, Yokohama City University27, Albert Einstein College of Medicine28
TL;DR: The GBD study provides annual updates on estimates of deaths, prevalence, and disability-adjusted life years (DALYs), a summary measure of fatal and non-fatal disease outcomes, for over 300 diseases and injuries, for 188 countries from 1990 to the most recent year.
1,601 citations
••
University of British Columbia1, University of Western Australia2, University Hospital of Lausanne3, University of Hong Kong4, National Institutes of Health5, University of Pittsburgh6, Charité7, University of Grenoble8, University of Wisconsin-Madison9, All India Institute of Medical Sciences10, Federal University of São Paulo11, University of California, San Diego12
TL;DR: This is the first study to report global prevalence of obstructive sleep apnoea; with almost 1 billion people affected, and with prevalence exceeding 50% in some countries, effective diagnostic and treatment strategies are needed to minimise the negative health impacts and to maximise cost-effectiveness.
1,487 citations